Herpes simplex virus infection in adult patients after unrelated cord blood transplantation: a single-institute experience in Japan
暂无分享,去创建一个
S. Asano | K. Uchimaru | A. Tojo | K. Tani | F. Nagamura | T. Iseki | J. Ooi | A. Tomonari | S. Takahashi | K. Takasugi | N. Ohno | Y. Shimohakamada | T. Yamada
[1] G. Sanz. Unrelated donor umbilical cord blood transplantation in adults with hematologic malignancies. , 2005, Pathologie-biologie.
[2] R. Reichman. Herpes simplex virus infections , 1984, European Journal of Clinical Microbiology.
[3] S. Asano,et al. Varicella‐zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan , 2003, British journal of haematology.
[4] S. Asano,et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. , 2003, Blood.
[5] S. Asano,et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan , 2003, British journal of haematology.
[6] M. Salavert,et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation , 2002, Bone Marrow Transplantation.
[7] P. Bolufer,et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. , 2001, Blood.
[8] J. Wagner,et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.
[9] Bernard Roizman,et al. Herpes simplex virus infections , 2001, The Lancet.
[10] D. Heilman,et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. , 2000, Blood.
[11] H. Esperou,et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] D. Pillay,et al. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. , 2000, The Journal of infectious diseases.
[13] H. Einsele,et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). , 1996, Bone marrow transplantation.
[14] D. Deluca,et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. R. Johnson,et al. Hepatitis due to herpes simplex virus in marrow-transplant recipients. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] N. Flournoy,et al. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. , 1984, Annals of internal medicine.
[17] L. Corey,et al. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. , 1982, Annals of internal medicine.
[18] O. Laskin,et al. Acyclovir prophylaxis of herpes-simplex-virus infections. , 1981, The New England journal of medicine.
[19] E Niskanen,et al. MARROW TRANSPLANTATION , 1977, Duodecim; laaketieteellinen aikakauskirja.